Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Status:
Terminated
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
Randomized, double blind placebo controlled clinical trial to evaluate effectiveness and
safety of inhaled nitric oxide for the treatment of sickle cell painful crisis in pediatric
patients with sickle cell disease.
Phase:
Phase 2
Details
Lead Sponsor:
Boston Children's Hospital Boston Children’s Hospital